Top

Published in:

01-07-2012

United States Trends in the Surgical Treatment of Primary Breast Cancer

Authors: Todd M. Tuttle, Natasha M. Rueth, Andrea Abbott, Beth A. Virnig

Published in: World Journal of Surgery | Issue 7/2012

Excerpt

Before the publication of National Surgical Adjuvant Breast Project Trial (NSABP) B-06, most breast cancer patients in the United States were treated with mastectomy [1, 2]. After the publication of NSABP-B06 in 1985, the rates of breast-conserving surgery (BCS) increased, but only slightly. After the 1990 National Institutes of Health Consensus Statement concluded that BCS plus radiation therapy (RT) was “preferred” for early-stage breast cancer, BCS rates markedly increased throughout the 1990s and early 2000s [2, 3]. However, during the past decade, several trends in the local treatment of breast cancer have been observed that are counter-intuitive to the findings from prospective randomized trials. …

Fisher B, Bauer M, Margolese R et al (1985) Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med 312:665–673PubMedCrossRef

Lazovich D, Solomon CC, Thomas DB et al (2000) Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma. Cancer 86:628–637CrossRef

National Institutes of Health consensus conference (1991) Treatment of early-stage breast cancer. JAMA 265:391–395CrossRef

McGuire KP, Santillan AA, Kaur P et al (2009) Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5,685 patients. Ann Surg Oncol 16:2682–2690PubMedCrossRef

Katipamula R, Degnim AC, Hoskin T et al (2009) Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol 27:4082–4088PubMedCrossRef

Morrow M (2009) More mastectomies: is this what patients really want? J Clin Oncol 27:4038–4040PubMedCrossRef

Balch CM, Jacobs LK (2009) Mastectomies on the rise for breast cancer: the tide is changing. Ann Surg Oncol 16:2669–2672PubMedCrossRef

Habermann EB, Abbott A, Parsons HM et al (2010) Are mastectomy rates really increasing in the United States? J Clin Oncol 28:3437–3441PubMedCrossRef

Nattinger AB, Gottlieb MS, Veum J et al (1992) Geographic variation in the use of breast-conserving treatment for breast cancer. N Engl J Med 326:1102–1107PubMedCrossRef

10.

Al-Refaie W, Kuerer HM, Khuwaja A et al (2005) Determinants of mastectomy in breast conservation therapy candidates. Am J Surg 190:602–605PubMedCrossRef

11.

Hershman DL, Buono D, Jacobson J et al (2009) Surgeon characteristics and use of breast conservation surgery in women with early stage breast cancer. Ann Surg 249:828–833PubMedCrossRef

12.

Gilligan MA, Kneusel RT, Hoffmann RG et al (2002) Persistent differences in sociodemographic determinants of breast conserving treatment despite overall increased adoption. Med Care 40:181–189PubMedCrossRef

13.

Hawley ST, Griggs JJ, Hamilton AS et al (2009) Decision involvement and receipt of mastectomy among racially and ethnically diverse breast cancer patients. J Natl Cancer Inst 101:1337–1347PubMedCrossRef

14.

Tuttle TM, Habermann EB, Grund EH et al (2007) Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol 25:5203–5209PubMedCrossRef

15.

Tuttle TM, Jarosek S, Habermann EB et al (2009) Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol 27:1362–1367PubMedCrossRef

16.

McLaughlin CC, Lillquist PP, Edge SB (2005) Surveillance of prophylactic mastectomy: trends in use from 1995 through 2005. Cancer 115:5404–5412CrossRef

17.

Sobero ME, Dick AW, Beckjord EB et al (2009) Diagnostic breast magnetic resonance imaging and contralateral prophylactic mastectomy. Ann Surg Oncol 16:1597–1605CrossRef

18.

Jones NB, Wilson J, Kotur L et al (2009) Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution. Ann Surg Oncol 16:2691–2696PubMedCrossRef

19.

Metcalfe KA, Lubinski J, Ghadirian P et al (2008) Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group. J Clin Oncol 26:1093–1097PubMedCrossRef

20.

Arrington AK, Jarosek SL, Virnig BA et al (2009) Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer. Ann Surg Oncol 16:2697–2704PubMedCrossRef

21.

Abbott A, Rueth N, Pappas-Varco S et al (2011) Perceptions of contralateral breast cancer: an overestimation of risk. Ann Surg Oncol 18:3129–3136PubMedCrossRef

22.

Black WC, Nease RF Jr, Tosteson AN (1995) Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. J Natl Cancer Inst 87:720–731PubMedCrossRef

23.

Alexander NE, Ross J, Sumner W et al (1996) The effect of an educational intervention on the perceived risk of breast cancer. J Gen Intern Med 11:92–97PubMedCrossRef

24.

Partridge A, Adloff K, Blood E et al (2008) Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study. J Natl Cancer Inst 100:243–251PubMedCrossRef

25.

Rakovitch E, Franssen E, Kim J et al (2003) A comparison of risk perception and psychological morbidity in women with ductal carcinoma in situ and early invasive breast cancer. Breast Cancer Res Treat 77:285–293PubMedCrossRef

26.

Frost MH, Schaid DJ, Sellers TA et al (2000) Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy. JAMA 284:319–324PubMedCrossRef

27.

Montgomery LL, Tran KN, Heelen MC et al (1999) Issues of regret in women with contralateral prophylactic mastectomies. Ann Surg Oncol 6:546–552PubMedCrossRef

28.

Geiger AM, Nekhlyudov L, Herrinton LJ et al (2007) Quality of life after bilateral prophylactic mastectomy. Ann Surg Oncol 14:686–694PubMedCrossRef

29.

Altschuler A, Nekhlyudov L, Rolnick SJ et al (2008) Positive, negative, and disparate: women’s differing long-term psychosocial experiences of bilateral or contralateral prophylactic mastectomy. Breast J 14:25–32PubMedCrossRef

30.

Herrinton LJ, Barlow WE, Yu O et al (2005) Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project. J Clin Oncol 23:4275–4286PubMedCrossRef

31.

Fisher B, Anderson S, Bryant J et al (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233–1241PubMedCrossRef

32.

Veronesi U, Saccozzi R, Del Vecchio M et al (1981) Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med 305:6–11PubMedCrossRef

33.

Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366:2087–2106

34.

Freedman RA, He Y, Winer EP et al (2009) Trends in racial and age disparities in definitive local therapy of early-stage breast cancer. J Clin Oncol 27:713–719PubMedCrossRef

35.

Malin JL, Kahn KL, Adams J et al (2002) Validity of cancer registry data for measuring the quality of breast cancer care. J Natl Cancer Inst 94:835–844PubMedCrossRef

36.

Daroui P, Gabel M, Khan AJ et al (2011) Utilization of breast conserving therapy in stages 0, I, and II breast cancer patients in New Jersey: an American College of Surgeons National Cancer Data Base (NCDB) analysis. Am J Clin Oncol. doi:10.1097/COC.0b013e318209aa57

37.

Hughes KS, Schnaper LA, Berry D et al (2004) Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 351:971–977PubMedCrossRef

38.

Tuttle TM, Jarosek S, Habermann EB et al. (2011) Omission of radiation therapy after breast-conserving surgery in the United States: a population-based analysis of clinicopathologic factors. Cancer. doi:10.1002/cncr.26505

39.

Nattinger AB, Kneusel RT, Hoffmann RG et al (2001) Relationship of distance from a radiotherapy facility and initial breast cancer treatment. J Natl Cancer Inst 93:1344–1346PubMedCrossRef

40.

Abbott AM, Habermann EB, Tuttle TM (2011) Trends in the use of implantable accelerated partial breast irradiation therapy for early stage breast cancer in the United States. Cancer 117:3305–3310PubMedCrossRef

41.

Hologic. MammoSite. Available at: http://www.mammosite.com. Accessed Jul 6 2010

42.

Gao X, Fisher SG, Emami B (2003) Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. Int J Radiat Oncol Biol Phys 56:1038–1045PubMedCrossRef

43.

Nichols HB, de González AB, Lacey JV Jr et al (2011) Declining incidence of contralateral breast cancer in the United States from 1975 to 2006. J Clin Oncol 29:1564–1569PubMedCrossRef

44.

Lostumbo L, Carbine N, Wallace J et al (2004) Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev (4):CD002748

45.

Peele PB, Siminoff LA, Xu Y et al (2005) Decreased use of adjuvant breast cancer therapy in a randomized controlled trial of a decision aid with individualized risk information. Med Decis Making 25:301–307PubMedCrossRef

46.

Sanghani M, Truong PT, Raad RA et al (2010) Validation of a web-based predictive nomogram for ipsilateral breast tumor recurrence after breast conserving therapy. J Clin Oncol 28:718–722PubMedCrossRef

47.

Bickell NA, Shastri K, Fei K et al (2008) A tracking and feedback registry to reduce racial disparities in breast cancer care. J Natl Cancer Inst 100:1717–1723PubMedCrossRef

48.

Whelan TJ, Pignol JP, Levine MN et al (2010) Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 362:513–520PubMedCrossRef

Title: United States Trends in the Surgical Treatment of Primary Breast Cancer
Authors: Todd M. Tuttle
Natasha M. Rueth
Andrea Abbott
Beth A. Virnig
Publication date: 01-07-2012
Publisher: Springer-Verlag
Published in: World Journal of Surgery / Issue 7/2012
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI: https://doi.org/10.1007/s00268-012-1469-4

At a glance: The STEP trials

Springer Medicine

United States Trends in the Surgical Treatment of Primary Breast Cancer

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 7/2012

Subcuticular Absorbable Suture with Subcutaneous Drainage System Prevents Incisional SSI after Hepatectomy for Hepatocellular Carcinoma

Identification of Risk Factors for Esophagojejunal Anastomotic Leakage after Gastric Surgery

The Need to Correct the Indication for Liver Resection in Cirrhotic Patients with Hepatocellular Carcinoma: Reply

Double Omental Flap Reduced Perianastomotic Collections and Relaparotomy Rates after Pancreaticoduodenectomy with Pancreaticogastrostomy

Prognostic Nutritional Index Predicts Outcomes of Gastrectomy in the Elderly

Evaluation of the Appendicitis Inflammatory Response Score for Patients with Acute Appendicitis